Résumé
OBJECTIVE: To investigate the relationship between ATP-binding cassette subfamily B member 1 (ABCB1) polymorphism and tacrolimus-related adverse drug reactions in renal transplant patients during perioperative period. METHODS: Totally 170 patients who underwent renal transplantation from Nov. 2014 to Mar. 2018 in our hospital as well as were tested for their ABCB1 C1236T (rs1128503), ABCB1 G2677T/A (rs2032582) and ABCB1 C3435T (rs1045642) genotype were selected in this study. χ2 test was used to compare the incidence of tacrolimus-related ADR among patients with different genotypes. The related adverse reactions included digestive tract reaction, pulmonary infection, renal dysfunction, abnormal liver function, elevated blood sugar, elevated blood lipid and decreased white blood cells. Logistic regression model was used to analyze the unit point risk. The main haplotypes of the above genes were analyzed by PHASE software, and their correlation with tacrolimus-induced ADR was analyzed. RESULTS: Among 170 patients, 21 cases (12.3%) of CC type, 78 cases (45.9%) of CT type and 71 cases (41.8%) of TT type were detected by ABCB1 C1236T (rs1128503). ABCB1 G2677T/A (rs2032582) test showed that 25 cases (14.7%) were GG type, 95 cases (55.9%) were GA+GT type and 50 cases (29.4%) were AA+AT+TT type. ABCB1 C3435T (rs1045642) test showed that 57 cases (33.5%) were CC type, 82 cases (48.2%) were CT type and 31 cases (18.3%) were TT type. There was no significant difference in the incidence of digestive tract reaction, pulmonary infection, renal dysfunction, elevated blood sugar, elevated blood lipid and decreased white blood cells among patients with different ABCB1 genotypes (P>0.05). However, there was significant difference in the incidence of abnormal liver function between ABCB1 C1236T (rs1128503) and ABCB1 C3435T (rs1045642) genotypes (P<0.05). There was no significant difference in the incidence of abnormal liver function among ABCB1 G2677T/A (rs2032582) genotypes (P=0.069), but P was lower than 0.1. Logistic regression analysis showed that ABCB1 C1236T (rs1128503) CC genotype [OR=4.959, 95%CI (1.700, 14.468), P=0.003], ABCB1 G2677T/A (rs2032582) GG genotype [OR=3.500, 95%CI (1.164, 10.524), P=0.026] and ABCB1 C3435T (rs1045642) CC genotype [OR=3.033, 95%CI (1.012, 9.095), P=0.048] were risk factors for tacrolimus-related abnormal liver function. ABCB1 CGC haplotype was the main haplotype. There was significant difference in the incidence of abnormal liver function caused by tacrolimus between ABCB1 CGC haplotype and non-ABCB1 CGC haplotype (P=0.002), and it was also a risk factor for tacrolimus-related liver dysfunction [OR=3.173, 95%CI(1.512, 6.656), P=0.002]. CONCLUSIONS: The abnormal liver function of ABCB1 CGC haplotype kidney transplantation patients is more likely to occur when tacrolimus is administered during the perioperative period.
Résumé
Objective@#To describe the distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015 to provide reference for empirical anti-infection treatment.@*Methods@#Pathogens were from hematology department of 26 tertiary hospitals in Jiangsu Province from 2014 to 2015. Antimicrobial susceptibility testing was carried out according to a unified protocol using Kirby-Bauer method or agar dilution method. Collection of drug susceptibility results and corresponding patient data were analyzed.@*Results@#The separated pathogens amounted to 4 306. Gram-negative bacteria accounted for 64.26%, while the proportions of gram-positive bacteria and funguses were 26.99% and 8.75% respectively. Common gram-negative bacteria were Escherichia coli (20.48%) , Klebsiella pneumonia (15.40%) , Pseudomonas aeruginosa (8.50%) , Acinetobacter baumannii (5.04%) and Stenotropho-monas maltophilia (3.41%) respectively. CRE amounted to 123 (6.68%) . Common gram-positive bacteria were Staphylococcus aureus (4.92%) , Staphylococcus hominis (4.88%) and Staphylococcus epidermidis (4.71%) respectively. Candida albicans were the main fungus which accounted for 5.43%. The rates of Escherichia coli and Klebsiella pneumonia resistant to carbapenems were 3.5%-6.1% and 5.0%-6.3% respectively. The rates of Pseudomonas aeruginosa resistant to tobramycin and amikacin were 3.2% and 3.3% respectively. The resistant rates of Acinetobacter baumannii towards tobramycin and cefoperazone/sulbactam were both 19.2%. The rates of Stenotrophomonas maltophilia resistant to minocycline and sulfamethoxazole were 3.5% and 9.3% respectively. The rates of Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis resistant wards vancomycin were 0, 6.4% and 1.4% respectively; also, the rates of them resistant to linezolid were 1.2%, 0 and 1.6% respectively; in addition, the rates of them resistant to teicoplanin were 2.8%, 14.3% and 8.0% respectively. Furthermore, MRSA accounted for 39.15% (83/212) .@*Conclusions@#Pathogens were mainly gram-negative bacteria. CRE accounted for 6.68%. The rates of Escherichia coli and Klebsiella pneumonia resistant to carbapenems were lower compared with other antibacterial agents. The rates of gram-positive bacteria resistant to vancomycin, linezolid and teicoplanin were still low. MRSA accounted for 39.15%.